Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy
The following is an excerpt from a press release from Sangamo Therapeutics. Read the press release in its entirety here. Sangamo Therapeutics Inc., a genomic medicine company, and Pfizer Inc. announced interim data from the Phase 1/2 Alta study evaluating investigational SB-525 gene therapy for severe hemophilia A. Data indicate that SB-525 was generally well-tolerated […]
Dear Addy: 5 Minutes for Project CALLS
Dear Addy, I am having a horrific time with my insurance company getting a prior authorization approved. I know I should call Project CALLS, but I simply don’t have time to be on the phone with the insurance company and Project CALLS. Why is it so important that I let HFA know what’s going on […]
English 
Español de Puerto Rico